Uniform colored and white coatings applied to tablets create a homogeneous appearance, improving patient compliance. Concerns about titanium dioxide have led to an increased interest in suitable alternatives. Calcium carbonate is currently seen as the most likely alternative.
This webinar highlights how particle engineering supports the optimal performance of calcium carbonate in coating applications, comparing our new alternative to titanium dioxide, the industry benchmark. We will present comprehensive study results of color measurements and provide you with tools on how to optimize coating formulation development and achieve appealing white finishings without titanium dioxide.
In this webinar, you will learn:
- The latest regulatory trends and implications in the EU for titanium dioxide, the extensively used colorant and opacifier in medicinal products
- How particle engineering supports optimal performance of calcium carbonate in film coatings, comparing the product to titanium dioxide
- How high efficiency can be maintained in the spraying process
- How color measurements and screening methods can be utilized to optimize the final finishing in the formulation development
Speakers
Almut von der Brelie
Merck
Senior Strategic Product Manager, Excipients Solid Application
As a food chemist by training, Almut von der Brelie has more than 17 years of experience in the global B2B marketing for functional cosmetic, food and pharmaceutical ingredients in highly regulated markets. In her current position as a strategic product manager, she is driving product innovations for solid dosage forms with a focus on the design of tablet film coatings and taste optimization.
Thomas Kipping, Ph.D.
Merck
Head of Drug Carriers
Dr. Thomas Kipping is an expert in the field of pharmaceutical technology and formulation development. Thomas is currently the head of drug carriers at Merck. With more than 10 years of industrial experience, spanning various sectors within the pharmaceutical industry, including drug product development and CDMO services, he has consistently demonstrated a strong commitment to advancing pharmaceutical sciences and enhancing drug development processes He holds a Ph.D. in pharmaceutical technology from the University of Bonn.
Pharma and biopharma manufacturing
- Pharma and biopharma manufacturing
期間:1h
言語:English
セッション 1:presented November 16, 2023
続きを確認するには、ログインするか、新規登録が必要です。
アカウントをお持ちではありませんか？